Form 8-K - Current report:
SEC Accession No. 0001493152-23-013528
Filing Date
2023-04-25
Accepted
2023-04-25 16:36:18
Documents
15
Period of Report
2023-04-19
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43608
2 ex99-1.htm EX-99.1 11860
3 ex99-1_001.jpg GRAPHIC 3870
  Complete submission text file 0001493152-23-013528.txt   287819

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bfrg-20230419.xsd EX-101.SCH 3939
5 XBRL DEFINITION FILE bfrg-20230419_def.xml EX-101.DEF 27004
6 XBRL LABEL FILE bfrg-20230419_lab.xml EX-101.LAB 37238
7 XBRL PRESENTATION FILE bfrg-20230419_pre.xml EX-101.PRE 25625
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5631
Mailing Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878
Business Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878 3013672055
BullFrog AI Holdings, Inc. (Filer) CIK: 0001829247 (see all company filings)

EIN.: 844786155 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41600 | Film No.: 23845383
SIC: 2834 Pharmaceutical Preparations